Related Experiment Videos
Surfactant replacement therapy in neonates with respiratory failure due to bacterial sepsis
W P Fetter1, W Baerts, A P Bos
1Department of Pediatrics, Sophia Hospital, Zwolle, The Netherlands.
Acta Paediatrica (Oslo, Norway : 1992)
|January 1, 1995
Abstract:
We describe four newborns (gestational ages 29-37 weeks; birthweights 1380-3040 grams) who were mechanically ventilated for respiratory insufficiency because of bacterial sepsis. A beneficial effect of bovine surfactant (Alvofact, dosages 50 or 100 mg/kg) was found, as shown by decreases in mean airway pressures and oxygen demands. No side effects were seen after instillation.